Labelling requirements for prescribed substance
77 Labelling requirements for prescribed substance
In addition to labelling requirements under the Poisons and Therapeutic Goods Act 1966, an authorised supplier who supplies a prescribed substance must attach a statement in writing to the relevant package or container that—
warns of the purpose of the dose of the substance, and
states the dangers of administration of the substance, and
states that, if the substance is supplied for self-administration—
the substance must be stored—
in a locked box that complies with the requirements stated in section 79, and
otherwise in accordance with other requirements provided by the authorised supplier, and
any unused or remaining substance must be given to an authorised disposer by the contact person for the patient to whom the substance is supplied.
The statement must be in the approved form.
This Act’s bill:Second reading speech
The statute text is free to read above. View subscription options to unlock the case-law research tools for each provision.